Understanding heart damage differences in breast cancer survivors
Unpacking the Multi-level Drivers of Cardiotoxicity Disparities in Breast Cancer Survivors
This study is looking at how different factors, like social support and healthcare experiences, can affect heart health in breast cancer survivors, especially focusing on differences between racial groups, to help improve care and outcomes for those at risk of heart problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10914206 on NIH RePORTER |
What this research studies
This research investigates the factors contributing to heart damage, known as cardiotoxicity, in breast cancer survivors, particularly focusing on racial disparities. It aims to explore how psychosocial and sociocultural elements, along with cancer care delivery, affect the risk of heart-related issues in these patients. By analyzing historical data and conducting cohort studies, the research seeks to identify specific drivers of these disparities and potential intervention points. The goal is to improve care and outcomes for breast cancer survivors who are at risk of cardiotoxicity.
Who could benefit from this research
Good fit: Ideal candidates for this research include breast cancer survivors, especially those aged 65 and older, and individuals from racial minority groups.
Not a fit: Patients who are not breast cancer survivors or those without a history of cardiotoxicity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that reduce the risk of heart damage in breast cancer survivors, particularly among those most affected by disparities.
How similar studies have performed: Previous research has shown that addressing psychosocial and sociocultural factors can effectively reduce health disparities, suggesting potential success for this approach.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Sutton, Arnethea La'shaun — Virginia Commonwealth University
- Study coordinator: Sutton, Arnethea La'shaun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.